denosumab
amgen,daiichi sankyo
['denosumab']
drug holiday? most benefits from bisphosph are within 3-5yr 10yr denosumab data 3yr teriparatide data recurrent use of romo problems with bisphos holidays -- risk of fractures so... switch therapies perhaps to denosumab
#reviewcourse
#acr22 #acrambassador
(pronounced VUH-neet sun-dhoo) Mother. She/Her/Hers. Rheumatologist. Program Director @lluhealth. Tweets are not medical advice. #ACRAmbassador @lluhphysicians